Achondroplasia Treatment Market, By Treatment Type (Vosoritide, Human Growth Hormone, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023

Code : CMI4161

Pages :207

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Restraints & Challenges:

High cost of drugs

Global Achondroplasia Treatment Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, were facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global achondroplasia treatment market. The COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the number of cancer patients increased in Pandemic, and so has the demand for the achondroplasia market. which is expected to hamper the global achondroplasia treatment market over the forecast period, owing to delayed clinical trials of products. For instance, the annual report of Ascendis Pharma A/S 2020, a biopharmaceutical company, stated that due to the pandemic, there was a potential impact on the conduct of clinical trials of investigational drug candidates.